Connect with us


Australian scientists seek COVID-19 cure through malaria vaccine



AUSTRALIAN researchers said it has made an important discovery in the race to find a COVID-19 vaccine.

The finding a ‘secret ingredient’ for an effective malaria vaccine which may be the breakthrough needed to find a solution to COVID-19.

The research from the Peter Doherty Institute at the University of Melbourne, published in peer-reviewed journal Cell & Host Microbe on Tuesday, found a way to prevent malaria from progressing from the liver.

Researchers at the Institute tested at four different points in time the blood samples of an otherwise healthy woman who was diagnosed with coronavirus.

They were able to record how her immune system responded to COVID-19, and how it was able to overcome the virus.  Laboratory Head Professor Katherine Kedzierska told SBS News the patient’s immune response was similar to that of a patient with influenza.

“When we were analysing the immune responses, we saw really textbook images of several different immune cell types emerging in the patient’s blood.”

“Even though COVID-19 is caused by a new virus, in an otherwise healthy person, we can generate a robust immune response across different cell types. This is an important step forward in understanding what drives recovery. Now we can do research on understanding what’s lacking, or what’s different in patients that have fatal disease outcomes,” she said.

In January, Doherty Institute researchers became the first outside China to successfully grow the Wuhan Coronavirus from a patient sample.

Research fellow Oanh Nguyen said it is the first time broad immune responses to COVID-19 have been reported.

“Three days after the patient was admitted, we saw large populations of several immune cells, which are often a tell-tale sign of recovery during seasonal influenza infection.We predicted that the patient would recover in three days, which is what happened.” Now by dissecting the immune response, scientists are a step closer to finding an effective Coronavirus vaccine.

But Professor Kedzierska said there are “many more questions” scientists are yet to answer.

“We’ve shown that this patient expressed antibodies, which are obviously important for the vaccine development,” she said.

“We still need to understand the nature of those antibodies, whether they can neutralise the virus or not. And it’s too early to tell if patients who’ve had the Coronavirus are immune from future infections.

We need to understand whether those immune responses can proceed into immunological memory [and whether] we still got those cells that can protect us against reinfection…with the same virus,” further stated.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *